Study: Artificial pancreas technology improves diabetes control in children
A study published in The New England Journal of Medicine found a closed-loop control system kept children ' s glucose levels in the target range longer than standard care. (Source: mobihealthnews)
Source: mobihealthnews - March 23, 2023 Category: Information Technology Source Type: news
Deadly parasite threatens California sea otters
Melissa Miller knew something was off when she began to examine a sea otter that had died in San Simeon, a coastal California town about halfway between San Francisco and Los Angeles, in the winter of 2020. Nearly all of the animal’s body fat was inflamed. “It felt like there were little bumps all through it,” she says—a condition the veterinary pathologist had never seen in her 25 years examining sea otters for the California Department of Fish and Wildlife. She also found unusual lesions in the pancreas and heart.
When Miller looked at the sea otter’s tissues under a microscope, she spotted a familiar foe...
Source: ScienceNOW - March 22, 2023 Category: Science Source Type: news
New approach could identify pancreatic cancer before it develops and spreads, study shares
The biomarker-based approach could spot pancreatic cancer before it forms and consequently intervene to help reduce your risk of the daunting condition. (Source: Daily Express - Health)
Source: Daily Express - Health - March 21, 2023 Category: Consumer Health News Source Type: news
Four tell-tale signs of steatorrhea that could signal pancreatic cancer - 'See your GP'
Despite its reluctance to show early warning signs, pancreatic cancer can trigger changes in your stool. (Source: Daily Express - Health)
Source: Daily Express - Health - March 18, 2023 Category: Consumer Health News Source Type: news
' Artificial Pancreas' Technology Boosts Blood Sugar Control for Young Kids With Type 1 Diabetes
FRIDAY, March 17, 2023 -- Just like adults, young children with type 1 diabetes may get the blood sugar control they need using an " artificial pancreas, " new research shows.
The Control-IQ artificial pancreas system was tested in a clinical trial in... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 17, 2023 Category: General Medicine Source Type: news
Artificial Pancreas'Superior' in Young Kids With Type 1 Diabetes Artificial Pancreas'Superior' in Young Kids With Type 1 Diabetes
A hybrid closed-loop automated insulin delivery system benefitted young children with type 1 diabetes aged 2-6 years compared to nonautomated insulin delivery, with mostly virtual care.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 15, 2023 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news
NIH-supported trial shows artificial pancreas improves blood glucose control in young children
Results are similar to findings seen in previous artificial pancreas trials in older children and adults. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - March 15, 2023 Category: American Health Source Type: news
Another Artificial Pancreas a Success in Tots With Type 1 Diabetes
(MedPage Today) -- Very young children with type 1 diabetes saw glycemic benefits when using a hybrid closed-loop system, the randomized PEDAP trial showed.
Among 102 children ages 2 to 5 years, the mean percentage of time that the glucose level... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 15, 2023 Category: Cardiology Source Type: news
Novo Nordisk Plans Price Cuts for Several Insulins
Novo Nordisk will start slashing some U.S. insulin prices up to 75% next year, following a path set earlier this month by rival Eli Lilly.
The Danish drugmaker said Tuesday that pre-filled pens and vials of long-acting and short-acting insulins will see price reductions. They include Levemir, Novolin, NovoLog and NovoLog Mix70/30.
Novo also will drop the list price of some unbranded products to match the lower price of the branded insulins.
The price cuts go into effect Jan. 1.
Eli Lilly and Co. said March 2 that it will cut the list prices for its most commonly prescribed insulin, Humalog, and for another insulin, Humulin...
Source: TIME: Health - March 14, 2023 Category: Consumer Health News Authors: Associated Press Tags: Uncategorized Drugs healthscienceclimate wire Source Type: news
£10 breath test for pancreatic cancer may save thousands as experts call it 'biggest breakthrough'
The test, done on a breathalyser-type device (pictured) in a GP surgery, was developed by Imperial College London researchers. (Source: the Mail online | Health)
Source: the Mail online | Health - March 11, 2023 Category: Consumer Health News Source Type: news
Eli Lilly ’s Price Cut Is Game-changing. But Insulin Isn’t the Only High Cost for People With Diabetes
Early each year, Kristin Thompson-Lerberg sits down with her husband to plan how they’ll reach their family’s insurance policy’s $3,000 deductible. The conversation is always short: Thompson-Lerberg needs about 8 vials of insulin each month to treat her Type-1 diabetes, and at $275 per vial before insurance kicks in, it takes just two months to reach the deductible from insulin alone.
But their budget expanded after pharmaceutical giant Eli Lilly announced on Mar. 1 that the monthly out-of-pocket prices of their insulin brands will soon be capped at $35 regardless of a person’s insurance. For Humalo...
Source: TIME: Health - March 7, 2023 Category: Consumer Health News Authors: Haley Weiss Tags: Uncategorized Health Care healthscienceclimate Source Type: news
Eli Lilly ’s Price Cut Is Gamechanging. But Insulin Isn’t the Only High Cost for People With Diabetes
Early each year, Kristin Thompson-Lerberg sits down with her husband to plan how they’ll reach their family’s insurance policy’s $3,000 deductible. The conversation is always short: Thompson-Lerberg needs about 8 vials of insulin each month to treat her Type-1 diabetes, and at $275 per vial before insurance kicks in, it takes just two months to reach the deductible from insulin alone.
But their budget expanded after pharmaceutical giant Eli Lilly announced on Mar. 1 that the monthly out-of-pocket prices of their insulin brands will soon be capped at $35 regardless of a person’s insurance. For Humalo...
Source: TIME: Health - March 7, 2023 Category: Consumer Health News Authors: Haley Weiss Tags: Uncategorized Health Care healthscienceclimate Source Type: news
Gene and cell therapies to combat pancreatic cancer
Pancreatic cancer is an incurable form of cancer, and gene therapies are currently in clinical testing to treat this deadly disease. A comprehensive review of the gene and cell biotherapies in development to combat pancreatic cancer is published in the peer-reviewed journal Human Gene Therapy. (Source: World Pharma News)
Source: World Pharma News - March 7, 2023 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Oncolytics Biotech ® Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights
Pancreatic cancer program advancing towards registration path supported by phase 1/2 GOBLET data showing a confirmed complete response and 69% objective response rate in advanced/metastatic patients. (Source: Reuters: Health)
Source: Reuters: Health - March 6, 2023 Category: Consumer Health News Source Type: news
The pancreatic cancer symptom that could be mistaken for the effects of a large meal
Symptoms of the disease can be "hard to spot", and often mistaken for other issues, the NHS warns. (Source: Daily Express - Health)
Source: Daily Express - Health - March 4, 2023 Category: Consumer Health News Source Type: news
